“Innovations in Insulin: New Opportunities to Individualize Therapy” – CMEs/CEs expire Aug. 30, 2018
Event Navigation
Content Areas
- Basal insulin
- Prandial insulin
- Cardiovascular safety
- Intensifying basal insulin
- Concentrated insulin
CME/CE Expires: Aug. 30, 2018
Presenters:
Vivian A. Fonseca, M.D. | Professor of Medicine and Pharmacology | Tullis-Tulane Alumni Chair in Diabetes | Chief, Section of Endocrinology | Tulane University School of Medicine and Jonathan D. Leffert, M.D. | Managing Partner, North Texas Endocrine Center | President, American Association of Clinical Endocrinologists
Target Audience: Primary Care Physicians, Nurses, Nurse Practitioners, Physician Assistants, Endocrinologists, other healthcare providers
CME/CE credit: Continuing Medical Education and Continuing Education credit is available for physicians, nurses and nurse practitioners
- The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.
- This program is accredited for 1.5 contact hours. Program ID #5539-EM.
- Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
- A maximum of 1.5 contact hours may be earned for successful completion of this activity.
- Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.5 contact hours.
_________________
This activity is supported by an independent educational grant from Novo Nordisk Inc.
This activity is supported by an educational grant from Lilly.
Questions should be directed to: (760) 773-4500 | cme@annenberg.net
